View drug registration information details.
Items | Registration information |
ID | 526 |
No | 526 |
Brand Name | HERCEPTIN 150MG |
Ingredients | TRASTUZUMAB 150 MG |
Dosage Form | POWDER FOR SOLUTION FOR INFUSION |
Primary Packaging | VIAL |
Storage | STORE 2-8 C |
Shelf Life | 4 YEARS |
Pack Size | 150 MG/VIAL/BOX |
Dispensing Category | Prescription only |
ATC Classification | XX |
Pharmaceutical Class | ANTINEOPLASTICS |
Indications | EARLY BREAST CANCER , METASTATIC BREAST CANCER AND ADVANCED GASTRIC CANCER |
Contraindications | HYPERSENSITIVITY |
Side Effects | FEVER AND CHILLS, ABDOMINAL PAIN, ASTHENIA, CHEST PAIN, HEADACHE, DIARRHEA, NAUSEA, VOMITING |
Unit Price | XXXX |
EDL |
No |
Description | WHITE TO PALE YELLOW LYOPHILIZED CAKE GIVES CLEAR TO SLIGHTLY OPALESCENT LIQUID, COLORLESS AFTER RECONSTITUTION |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | GENENTECH INC. |
Country | SWITZERLAND |
Import Registration No | 55 065 02 |
Import Registration Date | 2019-02-12 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2022-01-27 |
FDD Registration No | 04 I 5486/23 |
FDD Registration Date | 2023-04-25 |
Expiry Date | 2026-04-24 |
Back to drug list
|